Duck hepatitis A virus III type attenuated strain, live vaccine prepared from same and application of live vaccine
The invention discloses a duck hepatitis A virus III type attenuated strain, a live vaccine prepared from the same and application of the live vaccine and belongs to the field of separation and application of the duck hepatitis A virus strain. According to the invention, the duck hepatitis A virus I...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a duck hepatitis A virus III type attenuated strain, a live vaccine prepared from the same and application of the live vaccine and belongs to the field of separation and application of the duck hepatitis A virus strain. According to the invention, the duck hepatitis A virus III type strain JS with the microbial preservation number of CGMCC No.6852 is separated firstly; the strain is subjected to passage attenuated breeding to obtain a duck hepatitis A virus III type attenuated strain JS57 with stable characters, and the microbial preservation number of the duck hepatitis A virus III type attenuated strain JS57 is CGMCC No.9708. The invention also discloses a method for preparing a live vaccine used for preventing duck hepatitis by utilizing the duck hepatitis A virus III type attenuated strain. The prepared duck hepatitis A virus live vaccine has high immune protection efficiency, immuned ducks can obtain effective immune protection only, the safety is good, and the safety range is wide. |
---|